位置:首页 > 蛋白库 > BCRR_ENTFL
BCRR_ENTFL
ID   BCRR_ENTFL              Reviewed;         204 AA.
AC   Q5WNW9;
DT   05-JUN-2019, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   25-MAY-2022, entry version 54.
DE   RecName: Full=HTH-type transcriptional activator BcrR {ECO:0000305};
GN   Name=bcrR {ECO:0000303|PubMed:15388429};
OS   Enterococcus faecalis (Streptococcus faecalis).
OG   Plasmid pJM01.
OC   Bacteria; Firmicutes; Bacilli; Lactobacillales; Enterococcaceae;
OC   Enterococcus.
OX   NCBI_TaxID=1351;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   STRAIN=AR01/DGVS;
RX   PubMed=15388429; DOI=10.1128/aac.48.10.3743-3748.2004;
RA   Manson J.M., Keis S., Smith J.M.B., Cook G.M.;
RT   "Acquired bacitracin resistance in Enterococcus faecalis is mediated by an
RT   ABC transporter and a novel regulatory protein, BcrR.";
RL   Antimicrob. Agents Chemother. 48:3743-3748(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-10, FUNCTION, DNA-BINDING, ACTIVITY REGULATION,
RP   SUBCELLULAR LOCATION, AND DOMAIN.
RC   STRAIN=AR01/DGVS;
RX   PubMed=18227063; DOI=10.1074/jbc.m709503200;
RA   Gauntlett J.C., Gebhard S., Keis S., Manson J.M., Pos K.M., Cook G.M.;
RT   "Molecular analysis of BcrR, a membrane-bound bacitracin sensor and DNA-
RT   binding protein from Enterococcus faecalis.";
RL   J. Biol. Chem. 283:8591-8600(2008).
RN   [3]
RP   FUNCTION, ACTIVITY REGULATION, SUBCELLULAR LOCATION, DOMAIN, AND
RP   MUTAGENESIS OF ARG-11; SER-33; GLY-64; GLU-179 AND THR-183.
RX   PubMed=30777814; DOI=10.1099/mic.0.000781;
RA   Darnell R.L., Nakatani Y., Knottenbelt M.K., Gebhard S., Cook G.M.;
RT   "Functional characterization of BcrR: a one-component transmembrane signal
RT   transduction system for bacitracin resistance.";
RL   Microbiology 165:475-487(2019).
CC   -!- FUNCTION: Functions as both a membrane-bound sensor and transducer of
CC       bacitracin availability to activates transcription of the bcrABD operon
CC       in the presence of bacitracin (PubMed:15388429, PubMed:18227063,
CC       PubMed:30777814). Binds specifically to two inverted repeat sequences
CC       on the bcrABD promoter, irrespective of bacitracin concentration
CC       (PubMed:18227063). {ECO:0000269|PubMed:15388429,
CC       ECO:0000269|PubMed:18227063, ECO:0000269|PubMed:30777814}.
CC   -!- ACTIVITY REGULATION: Constitutively bound to the bcrABD promoter
CC       (PubMed:18227063, PubMed:30777814). Requires bacitracin for activation,
CC       probably through a conformational change, such as the oligomerization
CC       of inactive dimers to form active tetramers (PubMed:30777814).
CC       {ECO:0000269|PubMed:18227063, ECO:0000269|PubMed:30777814}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18227063,
CC       ECO:0000269|PubMed:30777814}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- DOMAIN: Contains an N-terminal helix-turn-helix DNA-binding domain, an
CC       intermediate oligomerization domain and a C-terminal transmembrane
CC       domain. {ECO:0000269|PubMed:18227063, ECO:0000269|PubMed:30777814}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY496968; AAS78452.1; -; Genomic_DNA.
DR   RefSeq; WP_002367752.1; NZ_QPZR01000029.1.
DR   AlphaFoldDB; Q5WNW9; -.
DR   SMR; Q5WNW9; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   CDD; cd00093; HTH_XRE; 1.
DR   Gene3D; 1.10.260.40; -; 1.
DR   InterPro; IPR001387; Cro/C1-type_HTH.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom_sf.
DR   Pfam; PF01381; HTH_3; 1.
DR   SMART; SM00530; HTH_XRE; 1.
DR   SUPFAM; SSF47413; SSF47413; 1.
DR   PROSITE; PS50943; HTH_CROC1; 1.
PE   1: Evidence at protein level;
KW   Activator; Antibiotic resistance; Cell membrane; Direct protein sequencing;
KW   DNA-binding; Membrane; Plasmid; Transcription; Transcription regulation;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..204
FT                   /note="HTH-type transcriptional activator BcrR"
FT                   /id="PRO_0000447368"
FT   TOPO_DOM        1..81
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30777814"
FT   TRANSMEM        82..102
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        103..126
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:30777814"
FT   TRANSMEM        127..147
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        148..154
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30777814"
FT   TRANSMEM        155..175
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        176..181
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:30777814"
FT   TRANSMEM        182..202
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        203..204
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:30777814"
FT   DOMAIN          7..61
FT                   /note="HTH cro/C1-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00257"
FT   DNA_BIND        18..37
FT                   /note="H-T-H motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00257"
FT   MUTAGEN         11
FT                   /note="R->K: Loss of activity. Does not affect DNA-binding
FT                   and cellular localization."
FT                   /evidence="ECO:0000269|PubMed:30777814"
FT   MUTAGEN         33
FT                   /note="S->L: Loss of activity. Does not affect DNA-binding
FT                   and cellular localization."
FT                   /evidence="ECO:0000269|PubMed:30777814"
FT   MUTAGEN         64
FT                   /note="G->D: Constitutively active. Does not affect DNA-
FT                   binding and cellular localization."
FT                   /evidence="ECO:0000269|PubMed:30777814"
FT   MUTAGEN         64
FT                   /note="G->S: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:30777814"
FT   MUTAGEN         179
FT                   /note="E->K: Loss of activity. Does not affect DNA-binding
FT                   and cellular localization."
FT                   /evidence="ECO:0000269|PubMed:30777814"
FT   MUTAGEN         183
FT                   /note="T->M: Loss of activity. Does not affect DNA-binding
FT                   and cellular localization."
FT                   /evidence="ECO:0000269|PubMed:30777814"
SQ   SEQUENCE   204 AA;  22887 MW;  DD35639F9581CD17 CRC64;
     MEFNEKLQQL RTGKNLTQEQ LAEQLYVSRT AISKWESGKG YPNMESLKCI SKFFSVTIDE
     LLSGEELITL AETENRSNLK KIYNYIYGIL DMMAVAFIFL PLYGNSVGGY VYAVNLLSFT
     ATTPFNLAVY WSAFAALIII GIGKIISTHL DKEKWGGIAT KCSLTITALA VCFFAAAREP
     YITVLVFLLL IGKIFVWIKQ MGMK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024